A. Z. Juniarto, “Salivary 17-hydroxyprogesterone (17-OHP) and androstenedione in monitoring efficacy of treatment among Indonesian Congenital Adrenal Hyperplasia Patients”, J ASEAN Fed Endocr Soc, vol. 27, no. 2, p. 203, May 2014.